Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Member Alert: IACP is Developing an HR 3204 FAQ, 12.5.13
Share |

 

 

 
Member Alert

Thursday, December 5, 2013
 
IACP is Developing an HR 3204 Frequently Asked Questions (FAQ) Guide for our Members; Send in Your Questions!
 
Thank you to the 327 Members who joined yesterday's IACP Town Hall Teleconference on HR 3204. We received a huge volume of questions, and are creating a comprehensive HR 3204 FAQ Guide for our membership. We will include all of the questions we received for the Town Hall, and also will cover your additional questions. So, please send in your requests!

Please email IACP at iacpinfo@iacprx.org with your HR 3204 questions by 12 pm EST tomorrow, Friday, December 6th.

IACP HR 3204 Town Hall Background:

HR 3204 is now the law.
On Monday, the FDA began introducing its proposed regulations, and also is accepting recommendations for a bulk drug substance list that is required by the newly enacted Drug Quality and Security Act. What does this mean for your practice? IACP leadership walked members through the law and answered your many questions.

IACP HR 3204 Town Hall Recording Now Available:

IACP's HR 3204 Town Hall was recorded (including the Q&A session) and can be found in the Members-only website. Select "Member Resources," and then click, "Town Hall Teleconference Recordings," to access. Please email us at iacpinfo@iacprx.org if you have any questions.


 
IACP is working to Protect, Promote & Advance Pharmacy Compounding. Thanks for being an IACP Member!
 

 

Stay connected to IACP by joining our online communities!

 

 

 

 

4638 Riverstone Blvd., Missouri City, TX 77459
iacpinfo@iacprx.org | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2013 International Academy of Compounding Pharmacists. All Rights Reserved.

Association Management Software Powered by YourMembership  ::  Legal